Walpar Nutritions Limited (NSE:WALPAR)
India · Delayed Price · Currency is INR 45.50
-2.35 (-4.91%)
At close: Jan 29, 2026
Walpar Nutritions Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 757.29 | 717.63 | 625.22 | 351.42 | 267.57 | 182.04 |
Other Revenue | 0.16 | 1.97 | 0.91 | 2.13 | 0.17 | 0.01 |
| 757.46 | 719.6 | 626.13 | 353.55 | 267.74 | 182.05 | |
Revenue Growth (YoY) | 17.66% | 14.93% | 77.10% | 32.05% | 47.07% | 8.93% |
Cost of Revenue | 589.45 | 567.14 | 498.6 | 241.5 | 210.56 | 128.87 |
Gross Profit | 168 | 152.46 | 127.53 | 112.05 | 57.18 | 53.18 |
Selling, General & Admin | 75.28 | 64.16 | 53.63 | 53.05 | 35.02 | 33.12 |
Other Operating Expenses | 31.8 | 28.7 | 24.89 | 20.56 | 11.57 | 5.99 |
Operating Expenses | 126.5 | 111.05 | 96.62 | 92.71 | 49.42 | 42.68 |
Operating Income | 41.5 | 41.41 | 30.91 | 19.34 | 7.76 | 10.5 |
Interest Expense | -2.9 | -2.44 | -6.34 | -7.57 | -4.44 | -5.18 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.07 | 0.1 | - |
Currency Exchange Gain (Loss) | 0.25 | 0.25 | 0.08 | -0.2 | -0.14 | -0.25 |
Other Non Operating Income (Expenses) | -0.45 | -0.45 | -0.35 | -0.37 | -0.4 | -0.17 |
EBT Excluding Unusual Items | 38.42 | 38.78 | 24.31 | 11.28 | 2.89 | 4.9 |
Gain (Loss) on Sale of Investments | - | - | 0.5 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.13 | - | - | - |
Other Unusual Items | - | - | - | -0.16 | -0.15 | - |
Pretax Income | 38.42 | 38.78 | 24.93 | 11.11 | 2.73 | 4.9 |
Income Tax Expense | 9.5 | 10.8 | 5.48 | 3.02 | -0.83 | 0.4 |
Earnings From Continuing Operations | 28.92 | 27.98 | 19.46 | 8.1 | 3.56 | 4.5 |
Minority Interest in Earnings | -5.6 | -4.74 | -3.64 | -2.2 | 0.25 | 0.01 |
Net Income | 23.31 | 23.24 | 15.82 | 5.9 | 3.81 | 4.51 |
Net Income to Common | 23.31 | 23.24 | 15.82 | 5.9 | 3.81 | 4.51 |
Net Income Growth | -5.71% | 46.92% | 168.11% | 55.00% | -15.51% | 269.95% |
Shares Outstanding (Basic) | 9 | 9 | 9 | 8 | 8 | 6 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 8 | 8 | 6 |
Shares Change (YoY) | 0.84% | 0.25% | 11.19% | - | 30.36% | 7.70% |
EPS (Basic) | 2.49 | 2.48 | 1.69 | 0.70 | 0.45 | 0.70 |
EPS (Diluted) | 2.49 | 2.48 | 1.69 | 0.70 | 0.45 | 0.69 |
EPS Growth | -6.49% | 46.56% | 141.12% | 55.00% | -34.50% | 239.90% |
Free Cash Flow | 9.92 | 17.76 | 34.79 | -41.43 | -49.28 | -65.29 |
Free Cash Flow Per Share | 1.06 | 1.89 | 3.71 | -4.92 | -5.85 | -10.10 |
Gross Margin | 22.18% | 21.19% | 20.37% | 31.69% | 21.36% | 29.21% |
Operating Margin | 5.48% | 5.75% | 4.94% | 5.47% | 2.90% | 5.77% |
Profit Margin | 3.08% | 3.23% | 2.53% | 1.67% | 1.42% | 2.48% |
Free Cash Flow Margin | 1.31% | 2.47% | 5.56% | -11.72% | -18.41% | -35.86% |
EBITDA | 60.73 | 59.4 | 49 | 38.44 | 10.59 | 14.06 |
EBITDA Margin | 8.02% | 8.25% | 7.83% | 10.87% | 3.95% | 7.73% |
D&A For EBITDA | 19.22 | 17.99 | 18.1 | 19.1 | 2.83 | 3.57 |
EBIT | 41.5 | 41.41 | 30.91 | 19.34 | 7.76 | 10.5 |
EBIT Margin | 5.48% | 5.75% | 4.94% | 5.47% | 2.90% | 5.77% |
Effective Tax Rate | 24.73% | 27.84% | 21.97% | 27.14% | - | 8.14% |
Revenue as Reported | 758.15 | 720.29 | 627.4 | 354.77 | 268.02 | 182.17 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.